Decreased dopamine activity predicts relapse in methamphetamine abusers

GJ Wang, L Smith, ND Volkow, F Telang, J Logan, D Tomasi, CT Wong, W Hoffman, M Jayne, N Alia-Klein, P Thanos, JS3261322 Fowler
2012-09-01
Abstract:Studies in methamphetamine (METH) abusers showed that the decreases in brain dopamine (DA) function might recover with protracted detoxification. However, the extent to which striatal DA function in METH predicts recovery has not been evaluated. Here we assessed whether striatal DA activity in METH abusers is associated with clinical outcomes. Brain DA D2 receptor (D2R) availability was measured with positron emission tomography and [11 C] raclopride in 16 METH abusers, both after placebo and after challenge with 60 mg oral methylphenidate (MPH)(to measure DA release) to assess whether it predicted clinical outcomes. For this purpose, METH abusers were tested within 6 months of last METH use and then followed up for 9 months of abstinence. In parallel, 15 healthy controls were tested. METH abusers had lower D2R availability in caudate than in controls. Both METH abusers and controls …
What problem does this paper attempt to address?